DV
Dividend Vision

AQST — Aquestive Therapeutics Inc

Aquestive Therapeutics Inc (AQST)

Total return is -73.5% over the past 8.1 years, 282.2 points behind SPY at 208.7%. Its deepest 1-year drawdown was 60.6%.

This is a single-stock equity holding in Aquestive Therapeutics Inc, a specialty pharmaceutical company. As an individual stock rather than a diversified fund, it carries no stated distribution rate or expense ratio typical of ETFs, and does not function as a dividend-focused investment vehicle. This holding appeals primarily to investors seeking direct exposure to a specific pharmaceutical company rather than those pursuing income through dividend distributions.

AQST key facts

Asset type
Stock
Asset class
Equity
Inception date
07/25/2018
Last close
$4.25
Market cap
$516,924,000
Average volume
4347900.0
Beta
1.445
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.61